Free provider profile
STEVEN PENNYBAKER, M.D.
NPI 1417371287
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2019-06-17.
401 PARNASSUS AVE, SAN FRANCISCO, CA, 94143
415-353-9111
2 practice locations listed
Enumerated 2014-02-13
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 practice locations listed — multi-site footprint.
- — 2 taxonomies listed — broader service mix.
- — Record last updated 7 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
70
Medicare patients
Not published
Part D drug cost
$4,442
Brand-name share
Not published
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Bupropion Xl (Bupropion Hcl) | 13 | $393 |
| Trazodone Hcl (Trazodone Hcl) | 11 | $219 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
202436 sessions · 13 patients · $46,849
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.